Pharmaceutical Technology on MSN6d
MeiraGTx and Hologen launch AI-backed gene therapy venture
The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...
MeiraGTx Holdings (MGTX) Partners with Hologen for $200M AI-Powered Parkinson’s Treatment
In comes, DeepSeek, a Chinese AI startup that has shown it is possible to develop AI models without spending much. It ...
Yahoo Finance6d
MeiraGTx and Hologen launch AI-backed gene therapy venture
Hologen has committed up to $430m in funding to support the development and commercialisation of AAV-GAD, MeiraGTx’s investigational gene therapy for Parkinson’s disease. The AI company will ...
Insider Monkey6d
Top 10 AI News Updates Taking Wall Street By Storm
On the other hand, Hologen Neuro Ltd is to receive up to $230 million from Hologen to fund the development of AAV GAD for treating Parkinson’s disease. Combining Hologen’s AI models with ...
MeiraGTx price target raised to $14 from $12 at BofA
BofA analyst Alec Stranahan raised the firm’s price target on MeiraGTx (MGTX) to $14 from $12 and keeps a Buy rating on the shares, citing a ...
Market Inference6d
MeiraGTx Releases Strong 10-K Report
MeiraGTx Holdings plc has recently released its 10-K report, offering insight into the company's financial condition and ...
SciELO6d
Effect of low- and high-dose methotrexate on wound healing in rats
1780370208 14 de Moura Estevão LR, Cassini-Vieira P, Leite AGB, de Carvalho Bulhões AAV, da Silva Barcelos L ... 1016/0030-4220(79)90080-x 23 Abdel-Maged AE, Gad AM, Wahdan SA, Azab SS. Efficacy and ...